APA (7th ed.) Citation

Trotta, F., Spila-Alegiani, S., Cas, R. D., Rajevic, M., Conti, V., Venegoni, M., . . . Traversa, G. (2017). Cardiovascular safety of tiotropium Respimat vs HandiHaler in the routine clinical practice: A population-based cohort study. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Trotta, Francesco, Stefania Spila-Alegiani, Roberto Da Cas, Maja Rajevic, Valentino Conti, Mauro Venegoni, Mariangela Rossi, and Giuseppe Traversa. Cardiovascular Safety of Tiotropium Respimat Vs HandiHaler in the Routine Clinical Practice: A Population-based Cohort Study. Public Library of Science (PLoS), 2017.

MLA (8th ed.) Citation

Trotta, Francesco, et al. Cardiovascular Safety of Tiotropium Respimat Vs HandiHaler in the Routine Clinical Practice: A Population-based Cohort Study. Public Library of Science (PLoS), 2017.